Serving Hancock Park, CA

GIST Specialist for Hancock Park, CA

GIST is a sarcoma, but it is not like the others. It has a targeted drug that works, and it barely responds to the chemotherapy and radiation used elsewhere in sarcoma. Getting the label right decides which of those you receive. Joshua Ellenhorn, MD, FACS is ten minutes west.

  • Confirmation of the GIST diagnosis against its mimics
  • Clinical Professor of Surgery, Cedars-Sinai Medical Center
  • Slides reviewed by sarcoma pathology within the same institution
  • Ten to fifteen minutes along Wilshire or 3rd
Endoscopic view of a submucosal tumor requiring diagnostic confirmation
~80%Of gastrointestinal mesenchymal tumors are GIST
Since 2000When GIST was separated from leiomyosarcoma
PoorlyHow GIST responds to conventional chemotherapy
CD117The stain that distinguishes it
A diagnosis that changed

GIST Was Only Recognised as Its Own Disease Recently

For most of the twentieth century, tumors arising in the wall of the digestive tract were classified as smooth muscle tumors: leiomyoma if they looked benign, leiomyosarcoma if they did not. That was a reasonable inference from what could be seen under a microscope, and it was wrong.

Around the turn of the century it became clear these tumors arise from an entirely different cell, the interstitial cell of Cajal, and that nearly all carry a mutation in the KIT gene. That discovery did more than rename a disease. It produced a drug. Imatinib was designed to block precisely that mutated signal, and its effect on advanced GIST was dramatic enough to become one of the defining results in modern oncology.

The practical consequence for a patient today is that the label carries treatment implications in both directions. A GIST misclassified as leiomyosarcoma may be given conventional chemotherapy, which works poorly against GIST, while never being offered the targeted drug that would have worked. A leiomyosarcoma misclassified as GIST may be put on imatinib that cannot help it, losing months during which effective treatment was available.

Immunohistochemistry is what separates them, and it is not always completely performed. A report describing a spindle cell tumor without CD117 or DOG1 results has not actually reached a diagnosis.

GIST specialist reviewing sarcoma pathology with a patient
Telling them apart

GIST Against the Tumors It Is Confused With

All of these can arise in or near the digestive tract and several share a similar appearance under the microscope. The treatment differs completely.

TumorHow it is identifiedHow it is treated
GISTCD117 and DOG1 positive. Usually a KIT or PDGFRA mutationComplete surgical removal, and targeted tablets for advanced disease. Chemotherapy and radiation are largely ineffective
LeiomyomaDesmin and smooth muscle actin positive, CD117 negativeFrequently no treatment at all. Benign smooth muscle tumor
LeiomyosarcomaDesmin and actin positive, CD117 negativeSurgery, with conventional chemotherapy and sometimes radiation having a genuine role. Does not respond to imatinib
SchwannomaS100 positiveBenign nerve sheath tumor. Removal if symptomatic, otherwise often left alone
Desmoid tumorCharacteristic nuclear beta-catenin stainingLocally aggressive but does not spread. Sometimes observed rather than resected
Solitary fibrous tumorSTAT6 positiveSurgery. Behaviour ranges widely and treatment differs from GIST entirely
Inflammatory fibroid polypBenign, with a PDGFRA mutation in some casesBenign and generally removed endoscopically if at all

A report stating spindle cell tumor without immunohistochemistry has described the appearance rather than reached a diagnosis. The stains above are what determine which disease you actually have.

Anatomy of a gastrointestinal stromal tumor within the digestive tract wall
Perspective

As Sarcomas Go, This Is a Favourable One

Being told you have a sarcoma is frightening, partly because most soft tissue sarcomas genuinely are difficult diseases with limited treatment options. It is worth knowing that GIST occupies an unusual position among them.

Complete surgical removal of a localised GIST with an intact capsule is often curative, and for most gastric tumors that operation is a modest one. Because these tumors rarely involve lymph nodes, the wide clearance other cancers demand is generally unnecessary. Where disease has spread, targeted therapy frequently controls it for years, and there is an established sequence of further drugs when resistance develops. Patients live for a long time with metastatic GIST that is being properly managed.

None of that applies to most other sarcomas, where surgery is often larger, drug options are more limited, and advanced disease is harder to control. If you have been reading general sarcoma material and finding it alarming, a good deal of it does not describe your situation.

In the operating room

The Operations, on Record

Recordings of real GIST resections narrated by the surgeon who performed them. The modest scale of these operations is part of what distinguishes GIST from sarcoma generally.

Laparoscopic Resection of a Gastric GIST

A gastric GIST removed through small incisions with the capsule kept intact.

Gastric GIST Resection: A Simplified Approach

A refined approach that shortens operating time and recovery.

Robotic Resection of a Duodenal GIST

Duodenal GIST removed robotically with the pancreas and bile duct preserved.

Check the report

Does Yours Name the Stains?

If your pathology says spindle cell tumor, or names a diagnosis without listing CD117 and DOG1 results, the classification has not been confirmed. A review of existing slides settles it without any new procedure.

Credentials

Certifications and Appointments

Two American Board of Surgery certifications, a Cedars-Sinai teaching appointment, and membership of the Society of Surgical Oncology and the American Society of Clinical Oncology.

Cedars-Sinai Medical CenterFellow of the American College of SurgeonsSociety of Surgical OncologyAmerican Society of Clinical OncologySuper Doctors recognition
  • American Board of Surgery, certified in General Surgery
  • American Board of Surgery, certified in Colorectal Surgery
  • California State Medical License
  • Florida State Medical License
Your surgeon

Joshua Ellenhorn, MD, FACS

Dr. Ellenhorn is a surgical oncologist and Clinical Professor of Surgery at Cedars-Sinai Medical Center, and a collaborative member of the Samuel Oschin Comprehensive Cancer Institute.

Sarcoma is a category rather than a disease, containing dozens of entities that behave differently and are treated differently. A general surgical oncologist covers the category. This practice concentrates on one member of it, which is what makes it possible to be confident that a tumor is a GIST rather than something adjacent, and to be equally confident when it is not. Sending a patient elsewhere because their tumor turns out to be a leiomyosarcoma is part of the job.

He is certified by the American Board of Surgery in General Surgery and in Colorectal Surgery, a Fellow of the American College of Surgeons, and a member of the Society of Surgical Oncology and the American Society of Clinical Oncology. He practises with the Surgery Group of Los Angeles.

Dr. Joshua Ellenhorn, MD, FACS, GIST surgeon serving Hancock Park, CA
Patient experience

What Patients Say

Reviews left by patients treated by Dr. Ellenhorn at the Surgery Group of Los Angeles.

★★★★★

I was very pleased with the office staff, they were always very pleasant and helpful. I was very impressed with Dr. Ellenhorn as well. He was very friendly and addressed all my concerns regarding my surgery and aftercare and follow up.

Terry Jackson
★★★★★

Very kind stuff, great service. Dr Joshua Ellenhorn is a very calm doctor who takes time with his patient.

Anita Lukacevic
Getting here

Ten Minutes From Hancock Park

Third Street west, or Wilshire west and then north, brings you to the medical plaza at 8635 W 3rd St in around ten to fifteen minutes. From the Larchmont and Windsor Square side, Highland south to 3rd and west is equally direct.

The office is attached to Cedars-Sinai Medical Center, and for the diagnostic question on this page that institutional setting is the substance. Distinguishing GIST from leiomyosarcoma or a desmoid tumor is a sarcoma pathology judgement, and having that expertise in the same building means slides can be reviewed and discussed rather than sent away and waited on.

Patients travelling from outside the region, including Arizona and Nevada, can have slides and imaging reviewed remotely.

GIST Specialist

8635 W 3rd St, Suite 880W
Los Angeles, CA 90048

(310) 356-3792

Monday to Saturday, 11:00am to 8:00pm
Closed Sunday

Hancock Park patient questions

Frequently Asked Questions

Is GIST the same as leiomyosarcoma?
No, though it used to be classified that way. Before the KIT mutation was identified around the turn of the century, most gastrointestinal stromal tumors were labelled leiomyoma or leiomyosarcoma of the digestive tract. They are now known to be a distinct disease with a completely different treatment.
Why does the distinction matter so much?
Because GIST has effective targeted therapy and most other sarcomas do not. Conversely, conventional chemotherapy and radiation work poorly against GIST while having a genuine role in other sarcomas. Getting the label wrong means being given treatment that cannot work while missing treatment that would.
Does chemotherapy work for GIST?
Conventional cytotoxic chemotherapy is largely ineffective against GIST. This surprises patients, because chemotherapy is what most people associate with cancer treatment. GIST is treated with targeted tablets that block the specific mutated signal driving it, which is a different mechanism entirely.
What about radiation?
Radiation has a very limited role in GIST, occasionally for symptom control in specific situations. It is not part of standard curative treatment. If radiation has been proposed as your main treatment for a GIST, that is worth a second opinion.
How do pathologists tell these tumors apart?
Immunohistochemistry. GIST is typically positive for CD117 and DOG1. Smooth muscle tumors such as leiomyosarcoma stain for desmin and actin instead. Nerve sheath tumors stain for S100. Desmoid tumors show a characteristic nuclear beta-catenin pattern. The stains are what settle it, not the appearance alone.
Is GIST considered a better diagnosis than other sarcomas?
In general terms, yes, and that is a reasonable thing to be told. Complete surgical removal is often curative, effective targeted drugs exist for advanced disease, and many patients live for years even with metastatic GIST. Compared with most soft tissue sarcomas that is a considerably more favourable position.
What if my report says spindle cell tumor without more detail?
That is a description rather than a diagnosis. Spindle cell morphology is shared by several tumors including GIST, leiomyoma, leiomyosarcoma and schwannoma. Immunohistochemistry is needed to determine which, and a report stopping at spindle cell tumor is incomplete.
How far is your office from Hancock Park?
Around ten to fifteen minutes. Wilshire or 3rd Street west, or Highland south to 3rd and then west. It is one of the shorter journeys of any neighbourhood this practice serves.

Confirm It Is a GIST Before Accepting Sarcoma Treatment.

Chemotherapy and radiation work poorly against GIST while targeted therapy works well. The immunohistochemistry on your pathology report is what determines which you should be receiving.

Call Now